SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-187297
Filing Date
2004-11-05
Accepted
2004-11-05 10:45:38
Documents
9
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2004 d10q.htm 10-Q 730886
2 EXECUTIVE HEALTH PLAN dex1076.htm EX-10.76 13254
3 FINANCIAL PLANNING BENEFIT PLAN dex1077.htm EX-10.77 14671
4 SUPPLEMENTAL LONG TERM DISABILITY PLAN dex1078.htm EX-10.78 6308
5 INVITROGEN CORPORATION DEFERRED STOCK UNIT PLAN dex1079.htm EX-10.79 64918
6 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8837
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8846
8 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4085
9 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4094
  Complete submission text file 0001193125-04-187297.txt   858483
Mailing Address 1600 FARADAY AVE CARLSBAD CA 92008
Business Address 1600 FARADAY AVE CARLSBAD CA 92008 7606037200
INVITROGEN CORP (Filer) CIK: 0001073431 (see all company filings)

IRS No.: 330373077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25317 | Film No.: 041121430
SIC: 2836 Biological Products, (No Diagnostic Substances)